Abstract
Objectives: The antioxidant enzyme catalase and the CO 2/HCO 3 − exchange enzyme carbonic anhydrase are both present in significant amounts in the cytosol of erythrocytes. The aim of the present study was to investigate whether these erythrocyte enzyme activities are altered in patients who have carcinoma. Design and methods: Cytosolic erythrocyte enzyme activities were measured in 108 cancer patients presenting with carcinoma at one of variable sites, prior to clinical treatment. These were compared with an age- and sex-matched control group of 31 healthy volunteers. Results: Mean (±SD) catalase activities did not differ significantly, i.e. 0.0035 (±0.0015) EU/ml in carcinoma patients vs. 0.0031 (±0.00075) EU/ml in controls. However, mean carbonic anhydrase activities of 204 (±91) EU/ml in the carcinoma patients were significantly higher than the 158 (±35) EU/ml in controls ( P value of 0.0065). Conclusion: Cytosolic erythrocyte carbonic anhydrase levels may warrant further investigation as a potential peripheral marker in cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
